Skip to content

Drug interactions

Cannabidiol + Efavirenz

Severity: Moderate

Cannabidiol and Efavirenz: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz induces CYP3A4 and CYP2B6 and may lower cannabidiol exposure, while its CYP2C19 effects are mixed. Cannabidiol can also inhibit CYP2C19 and CYP2B6 pathways, altering efavirenz exposure. Efficacy and tolerability of cannabidiol may change.

What this interaction means in plain words

Cannabidiol and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cannabidiol belongs to Central Nervous System; Efavirenz belongs to Anti Virals.

Evidence level: Low

Why it happens

Efavirenz induction of CYP3A4 and CYP2B6 and cannabidiol effects on CYP2C19 and CYP2B6 alter exposure of both drugs.

What to do

Monitor seizure control and adverse effects, and titrate cannabidiol according to response. Monitor liver enzymes and HIV viral load.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cannabidiol and Efavirenz, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cannabidiol with Efavirenz?

MediHelp rates the interaction as moderate. Cannabidiol and Efavirenz can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz induces CYP3A4 and CYP2B6 and may lower cannabidiol exposure, while its CYP2C19 effects are mixed. Cannabidiol can also inhibit CYP2C19 and CYP2B6 pathways, altering efavirenz exposure. Efficacy and tolerability of cannabidiol may change.

How serious is the interaction between Cannabidiol and Efavirenz?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor seizure control and adverse effects, and titrate cannabidiol according to response. Monitor liver enzymes and HIV viral load.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in